Radio-immunotherapy: the focused beam expands

Affiliations

¹ Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 27, 91054 Erlangen, Germany. Electronic address: benjamin.frey@uk-erlangen.de.
² Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 27, 91054 Erlangen, Germany.

Comment

Benjamin Frey et al. Lancet Oncol. 2015 Jul.

. 2015 Jul;16(7):742-3.

doi: 10.1016/S1470-2045(15)00055-8. Epub 2015 Jun 18.

¹ Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 27, 91054 Erlangen, Germany. Electronic address: benjamin.frey@uk-erlangen.de.
² Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 27, 91054 Erlangen, Germany.

No abstract available

Comment on

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.
Golden EB, Chhabra A, Chachoua A, Adams S, Donach M, Fenton-Kerimian M, Friedman K, Ponzo F, Babb JS, Goldberg J, Demaria S, Formenti SC. Golden EB, et al. Lancet Oncol. 2015 Jul;16(7):795-803. doi: 10.1016/S1470-2045(15)00054-6. Epub 2015 Jun 18. Lancet Oncol. 2015. PMID: 26095785 Clinical Trial.